Atlas Trials

A Study of CS3007 in Subjects With Gastrointestinal Stromal Tumor

Clinical trial NCT04254939 · COMPLETED

Trial details

NCT number
NCT04254939
Sponsor
CStone Pharmaceuticals
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Gastrointestinal Stromal Tumors
Start date
2019-08-15
Primary completion
2020-04-30
Enrollment
65

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.